BR-body mutant mRNA half-life profiling.
收藏NIAID Data Ecosystem2026-04-25 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP212634
下载链接
链接失效反馈官方服务：
资源简介：
BR-body mutant strains were globally profiled for mRNA half-lives using rifampicin treatment followed by RNA-seq. JS38 (wild type) was compared to JS221 (lacking the intrinsically disordered CTD and unable to form BR-bodies), JS233 (unable to recruit degradosome components into BR-bodies), and JS299 (active site mutant of RNase E). Overall design: BR-body mutant strains were globally profiled for mRNA half-lives using rifampicin treatment followed by RNA-seq. Biological samples were taken before treatment, then at 1, 3, and 9 minutes after rifampicin treatment.
创建时间：
2019-07-08
